Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001510281-25-000090

10% owner sold 36,536 shares at $13.75 ($502,370)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saba Capital Management, L.P. 10% owner 2025-02-12 Sale −36,536 $13.75 $502,370 3,276,181 I
Open-market sales · 36,536 sh · avg $13.75 · $502,370
Loading xslF345X05/primary_doc.xml…